Faculdade de Medicina FMUSP, Universidade de Sao Paulo, Sao Paulo, Brasil.
Obstetrics and Gynecology Department, Hôpital Antoine-Béclère, Assistance Publique-Hôpitaux de Paris (AP-HP), Clamart, France.
PLoS One. 2021 Feb 3;16(2):e0246392. doi: 10.1371/journal.pone.0246392. eCollection 2021.
To compare maternal complications and describe neonatal outcomes in women with severe preeclampsia at ≤ 26+0 weeks in two countries with different management policies: expectant management (Brazil) versus termination of pregnancy (France).
We conducted a retrospective comparative study by reviewing the medical records of women with severe preeclampsia at ≤ 26+0 weeks, from January 2010 to June 2018, in two centers: Hospital das Clínicas da Faculdade de Medicina, in Sao Paulo, Brazil (where medical abortion is forbidden in this indication) and Hôpital Antoine-Béclère, Clamart, France (where medical termination is accepted). We collected information on maternal characteristics, laboratory tests, maternal complications and fetal and newborn characteristics. We used Student's t-test and the Mann-Whitney U nonparametric test to compare quantitative variables, and Chi-square test or Fisher's exact test to evaluate the associations between the qualitative variables.
There was no between-group difference in maternal complications during hospitalization (p = 0.846). In Brazil, the rate of cesarean section was 66.7%, and 20% of patients had vertical incision. The rate of spontaneous fetal death was 35.6% and among the live-born infants 26.6% were discharged from hospital. In France, one patient had a cesarean section with vertical incision.
When comparing termination of pregnancy to expectant management in severe preeclampsia before 26 weeks, maternal complications were equivalent but maternal reproductive future might have been compromised in 20% of cases due to a higher risk of uterine rupture in subsequent pregnancies for patients having classic cesarean (vertical incision). 26.6% of children survived the neonatal period when pregnancy was pursued, however we lack information on their long-term follow-up.
比较两种不同管理政策下≤26+0 周重度子痫前期产妇的母体并发症和新生儿结局:期待治疗(巴西)与终止妊娠(法国)。
我们对 2010 年 1 月至 2018 年 6 月在两个中心的≤26+0 周重度子痫前期患者的病历进行回顾性比较研究:巴西圣保罗的 Faculdade de Medicina 医院(在此适应证中禁止药物流产)和法国 Clamart 的 Hôpital Antoine-Béclère(在此适应证中接受药物终止妊娠)。我们收集了产妇特征、实验室检查、母体并发症以及胎儿和新生儿特征等信息。我们使用 Student's t 检验和 Mann-Whitney U 非参数检验比较定量变量,用卡方检验或 Fisher 确切概率法评估定性变量之间的关联。
两组患者住院期间的母体并发症无差异(p=0.846)。在巴西,剖宫产率为 66.7%,20%的患者行垂直切口。胎儿自然死亡率为 35.6%,活产儿中 26.6%出院。在法国,1 例患者行剖宫产,行垂直切口。
在 26 周前重度子痫前期中比较终止妊娠与期待治疗,母体并发症相当,但因经典剖宫产(垂直切口)后再次妊娠子宫破裂风险较高,20%的患者可能会影响到生殖预后。继续妊娠的新生儿中 26.6%存活下来,但我们缺乏关于他们长期随访的信息。